ETX.L - e-Therapeutics plc

LSE - LSE Delayed Price. Currency in GBp
7.10
0.00 (0.00%)
At close: 12:54PM BST
Stock chart is not supported by your current browser
Previous Close7.10
Open7.05
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.05 - 7.05
52 Week Range6.70 - 12.25
Volume67,000
Avg. Volume17,962
Market Cap19.071M
Beta-0.23
PE Ratio (TTM)N/A
EPS (TTM)-2.00
Earnings DateSep 21, 2017 - Sep 22, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.00
  • ACCESSWIRE3 months ago

    Edison Issues Update On e-Therapeutics (ETX)

    LONDON, UK / ACCESSWIRE / April 23, 2018 / With the refocusing of the business and the new CEO's strategic review now implemented, e-Therapeutics (LSE: ETX) finds itself with the NDD platform and at least ...

  • Business Wire4 months ago

    e-therapeutics plc: Full Year Results

    e-therapeutics plc , the drug discovery company, announces its full year results for the year ended 31 January 2018.

  • ACCESSWIRE6 months ago

    Edison Issues Update on e-Therapeutics (ETX)

    LONDON, UK / ACCESSWIRE / January 5. 2018 / e-Therapeutics' (LSE: ETX) Network-Driven Drug Discovery (NDD) platform has begun to deliver encouraging data that should support out-licensing of its immuno-oncology ...

  • What’s Installed For e-Therapeutics plc (LON:ETX)?
    Simply Wall St.7 months ago

    What’s Installed For e-Therapeutics plc (LON:ETX)?

    e-Therapeutics plc (AIM:ETX), a GBP£24.83M small-cap, operates in the healthcare industry, which faces key trends such as rising demand fuelled by an aging population and the growing prevalence of chronicRead More...

  • Is It The Right Time To Buy e-Therapeutics plc (AIM:ETX)?
    Simply Wall St.9 months ago

    Is It The Right Time To Buy e-Therapeutics plc (AIM:ETX)?

    e-Therapeutics plc (AIM:ETX), a biotechnology company based in United Kingdom, received a lot of attention from a substantial price movement on the AIM in the over the last few months,Read More...

  • Have Investors Already Priced In e-Therapeutics plc’s (AIM:ETX) Growth?
    Simply Wall St.10 months ago

    Have Investors Already Priced In e-Therapeutics plc’s (AIM:ETX) Growth?

    e-Therapeutics plc (AIM:ETX), a pharmaceuticals, biotechnology and life sciences company based in United Kingdom, received a lot of attention from a substantial price movement on the AIM in the overRead More...

  • Business Wirelast year

    e-Therapeutics Announces Outcome of Strategic Review and Future Plans

    e-Therapeutics plc : Upon the completion of Ray Barlow’s first three months as CEO of e-Therapeutics, the Company outlines below the conclusion of the strategic review for its investors and other stakeholders.